The Urotensin II System And Carotid Atherosclerosis: A Role In Vascular Calcification

The Urotensin II System And Carotid Atherosclerosis: A Role In Vascular Calcification

Background and aims: The aims of the present study were to determine the expression of urotensin II (UII), urotensin-II related peptide (URP) and their receptor (UT) in stable and unstable carotid atherosclerosis, and determine the effects of UII on human aortic smooth muscle cell (SMCs) calcificati...

Full description

Bibliographic Details
Main Authors:	Isabella eAlbanese, Stella S Daskalopoulou, Bin eYu, Zhipeng eYou, Jacques eGenest, Alawi eAlsheikh-Ali, Adel Giaid Schwertani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-06-01
Series:	Frontiers in Pharmacology
Subjects:	Calcium Immunohistochemistry smooth muscle cells urotensin II UT Urotensin II-related peptide
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00149/full

Similar Items

The Effect of Silymarin on the Expression of Urotensin–II and Urotensin–II Receptor Genes in the Liver Tissue of Type 2 Diabetic Rats
by: N Kheiripour, et al.
Published: (2019-12-01)

The Effect of Silymarin on the Expression of Urotensin–II and Urotensin–II Receptor Genes in the Liver Tissue of Type 2 Diabetic Rats
by: N Kheiripour, et al.
Published: (2019-04-01)

Effects of urotensin II receptor antagonist, GSK1440115, in asthma
by: Alison D Portnoy, et al.
Published: (2013-04-01)

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands
by: Roberta d'Emmanuele di Villa Bianca, et al.
Published: (2015-02-01)

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
by: Vadim Le Joncour, et al.
Published: (2021-04-01)

The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features
by: Hélène Castel, et al.
Published: (2017-04-01)

Effects of CBD supplementation on ambulatory blood pressure and serum urotensin-II concentrations in Caucasian patients with essential hypertension: A sub-analysis of the HYPER-H21-4 trial
by: Marko Kumric, et al.
Published: (2023-08-01)

Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
by: Ante Mihovilovic, et al.
Published: (2023-05-01)

Relationship between cardiac rhythm disorders, serum urotensin ІІ and angiotensin ІІ levels in patients with stage ii hypertension and carotid atherosclerosis in dynamics of treatment with candesartan and lercanidipine
by: O. V. Demidenko,, et al.
Published: (2016-10-01)

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits
by: Qingqing Yu, et al.
Published: (2023-02-01)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
by: Ibrahim Elmadbouh, et al.
Published: (2017-06-01)

Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients
by: Eray Metin Guler, et al.
Published: (2021-04-01)

Update on the urotensinergic system: new trends in receptor localization, activation and drug design
by: David eChatenet, et al.
Published: (2013-01-01)

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
by: Na Li, et al.
Published: (2022-12-01)

The relationship between anxiety and serum urotensin-II and S100B levels in patients with essential hypertension (eng)
by: Aslı Kazğan, et al.
Published: (2021-09-01)

Changes in the electrophysiological parameters of the posterior intestine of Anguilla anguilla (Pisces) induced by oxytocin, urotensin II and aldosterone
by: B. Baldisserotto, et al.
Published: (1997-01-01)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
by: Marko Simunovic, et al.
Published: (2022-02-01)

Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
by: Benjamin Poret, et al.
Published: (2020-03-01)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in the unanesthethized trout
by: Gilmer eVanegas, et al.
Published: (2015-04-01)

Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia
by: Li-Jie Zhang, et al.
Published: (2017-07-01)

Role of Urotensin-II in Saphenous Vein Graft Disease
by: Mehmet Erin Tüysüz, et al.
Published: (2020-06-01)

Urotensin II Induces Mice Skeletal Muscle Atrophy Associated with Enhanced Autophagy and Inhibited Irisin Precursor (Fibronectin Type III Domain Containing 5) Expression in Chronic Renal Failure
by: Ya-Jing Pan, et al.
Published: (2019-06-01)

Urotensin Ⅱ receptor antagonist(urantide) alleviates renal injury in rats with atherosclerosis
by: LIU Yifei, WANG Xinyu, WANG Jiahui, DU Xiaobing, WANG Tu, ZHAO Juan
Published: (2023-11-01)

Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice
by: Xin-Xin Pang, et al.
Published: (2016-07-01)

An investigation of postmortem urotensin II receptor levels in brain and kidney tissues in a rat model of cardiac ischemia
by: Mustafa Talip Sener, et al.
Published: (2018-01-01)

Urotensin II-related peptides, Urp1 and Urp2, control zebrafish spine morphology
by: Elizabeth A Bearce, et al.
Published: (2022-12-01)

Inhibition of U‐II/UT signaling ameliorates cystitis‐associated bladder hyperactivity by targeting the RhoA/Rho‐kinase pathway
by: Qian Liu, et al.
Published: (2022-09-01)

Smad2/3 signaling involved in urotensin II-induced phenotypic differentiation, collagen synthesis and migration of rat aortic adventitial fibroblasts
by: Weizhao Lin, et al.
Published: (2023-08-01)

Urotensin II promotes secretion of LTB4 through 5-lipoxygenase via the UT-ROS-Akt pathway in RAW264.7 macrophages
by: Dan Lu, et al.
Published: (2019-05-01)

Impact of Classic Adrenal Secretagogues on mRNA Levels of Urotensin II and Its Receptor in Adrenal Gland of Rats
by: Karol Jopek, et al.
Published: (2023-08-01)

Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions
by: Turgay Ulas, et al.
Published: (2013-01-01)

Effects of Thymoquinone on Urotensin-II and TGF-β1 Levels in Model of Osteonecrosis in Rats
by: Mehmet Yilmaz, et al.
Published: (2023-10-01)

Features of 24-hour monitoring of blood pressure, serum urotensin II and angiotensin II levels, vascular remodeling and extracranial blood flow in patients with hypertension
by: V. A. Vizir, et al.
Published: (2015-12-01)

Dynamic Responses of the Caudal Neurosecretory System (CNSS) Under Thermal Stress in Olive Flounder (Paralichthys olivaceus)
by: Mingzhe Yuan, et al.
Published: (2020-01-01)

Conserved role of the urotensin II receptor 4 signalling pathway to control body straightness in a tetrapod
by: Faredin Alejevski, et al.
Published: (2021-08-01)

Aldosterone is a possible new stimulating factor for promoting vascular calcification
by: Xusheng Zhang, et al.
Published: (2021-11-01)

The urotensin II receptor antagonist DS37001789 ameliorates mortality in pressure-overload mice with heart failure
by: Mina Nishi, et al.
Published: (2020-02-01)

Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice
by: Xi Chen, et al.
Published: (2019-07-01)

Effect of urotensin II on apolipoprotein B 100 and apolipoprotein A-I expression in HepG2 cell line
by: Abbas Mohammadi, et al.
Published: (2014-01-01)

Urotensin II promotes the proliferation and secretion of vascular endothelial growth factor in rat dermal papilla cells by activating the Wnt-β-catenin signaling pathway
by: Congjuan Liao, et al.
Published: (2023-06-01)